Gossamer Bio, Inc. (GOSS)
0.4224
-0.03
(-6.55%)
USD |
NASDAQ |
Mar 20, 16:00
0.402
-0.02
(-4.83%)
After-Hours: 20:00
Gossamer Bio Research and Development Expense (Quarterly) : 48.93M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 29.01M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Kyntra Bio, Inc. | 7.268M |
| Artelo Biosciences, Inc. | 0.893M |
| Axsome Therapeutics, Inc. | 48.68M |